A carregar...
Essential thrombocythemia treatment algorithm 2018
Current drug therapy for myeloproliferative neoplasms, including essential thrombocythemia (ET) and polycythemia vera (PV), is neither curative nor has it been shown to prolong survival. Fortunately, prognosis in ET and PV is relatively good, with median survivals in younger patients estimated at 33...
Na minha lista:
| Publicado no: | Blood Cancer J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802626/ https://ncbi.nlm.nih.gov/pubmed/29321520 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0041-8 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|